VERTEX PHARMACEUTICALS INC / MA Earnings Per Share (Diluted)
VERTEX PHARMACEUTICALS INC / MA (VRTX) reported Earnings Per Share (Diluted) of $4.31 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-04
- VERTEX PHARMACEUTICALS INC / MA earnings per share, diluted for the quarter ending 2026-06-30 was $4.31, a 8.02% increase year-over-year.
- VERTEX PHARMACEUTICALS INC / MA earnings per share, diluted for the quarter ending 2026-03-31 was $4.02, a 61.45% increase year-over-year.
- VERTEX PHARMACEUTICALS INC / MA earnings per share, diluted for the quarter ending 2025-09-30 was $4.20, a 4.74% increase year-over-year.
- VERTEX PHARMACEUTICALS INC / MA earnings per share, diluted for the quarter ending 2025-06-30 was $3.99.
- VERTEX PHARMACEUTICALS INC / MA earnings per share, diluted for fiscal 2025 was $15.32.
- VERTEX PHARMACEUTICALS INC / MA earnings per share, diluted for fiscal 2024 was -$2.08, a 114.97% decline from fiscal 2023.
- VERTEX PHARMACEUTICALS INC / MA earnings per share, diluted for fiscal 2023 was $13.89, a 8.35% increase from fiscal 2022.
- VERTEX PHARMACEUTICALS INC / MA earnings per share, diluted for fiscal 2022 was $12.82, a 42.29% increase from fiscal 2021.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.31 10-Q · filed 2026-08-04 | $8.33 10-Q · filed 2026-08-04 | ||
| 2026-03-31 | $4.02 10-Q · filed 2026-05-05 | |||
| 2025-12-31 | $15.32 10-K · filed 2026-02-13 | |||
| 2025-09-30 | $4.20 10-Q · filed 2025-11-04 | $10.68 10-Q · filed 2025-11-04 | ||
| 2025-06-30 | $3.99 10-Q · filed 2026-08-04 | $6.48 10-Q · filed 2026-08-04 | ||
| 2025-03-31 | $2.49 10-Q · filed 2026-05-05 | |||
| 2024-12-31 | -$2.08 10-K · filed 2026-02-13 | |||
| 2024-09-30 | $4.01 10-Q · filed 2025-11-04 | -$5.61 10-Q · filed 2025-11-04 | ||
| 2024-06-30 | -$13.92 10-Q · filed 2025-08-05 | -$9.66 10-Q · filed 2025-08-05 | ||
| 2024-03-31 | $4.21 10-Q · filed 2025-05-06 | |||
| 2023-12-31 | $13.89 10-K · filed 2026-02-13 | |||
| 2023-09-30 | $3.97 10-Q · filed 2024-11-05 | $10.18 10-Q · filed 2024-11-05 | ||
| 2023-06-30 | $3.52 10-Q · filed 2024-08-02 | $6.21 10-Q · filed 2024-08-02 | ||
| 2023-03-31 | $2.69 10-Q · filed 2024-05-07 | |||
| 2022-12-31 | $12.82 10-K · filed 2025-02-13 | |||
| 2022-09-30 | $3.59 10-Q · filed 2023-11-07 | $9.68 10-Q · filed 2023-11-07 | ||
| 2022-06-30 | $3.13 10-Q · filed 2023-08-02 | $6.09 10-Q · filed 2023-08-02 | ||
| 2022-03-31 | $2.96 10-Q · filed 2023-05-02 | |||
| 2021-12-31 | $9.01 10-K · filed 2024-02-15 | |||
| 2021-09-30 | $3.28 10-Q · filed 2022-10-28 | $6.03 10-Q · filed 2022-10-28 | ||
| 2021-06-30 | $0.26 10-Q · filed 2022-08-05 | $2.75 10-Q · filed 2022-08-05 | ||
| 2021-03-31 | $2.49 10-Q · filed 2022-05-06 | |||
| 2020-12-31 | $2.30 10-K · filed 2021-02-11 | $10.29 10-K · filed 2023-02-10 | ||
| 2020-09-30 | $2.53 10-Q · filed 2021-11-03 | $7.98 10-Q · filed 2021-11-03 | ||
| 2020-06-30 | $3.18 10-Q · filed 2021-07-30 | $5.46 10-Q · filed 2021-07-30 | ||
| 2020-03-31 | $2.29 10-Q · filed 2021-04-30 | |||
| 2019-12-31 | $2.23 10-K · filed 2021-02-11 | $2.45 derived: net income ÷ weighted average shares · filed 2021-02-11 | $3.48 derived: net income ÷ weighted average shares · filed 2021-02-11 | $4.51 10-K · filed 2022-02-09 |
| 2019-09-30 | $0.22 10-K · filed 2021-02-11 | $1.25 derived: net income ÷ weighted average shares · filed 2021-02-11 | $2.28 10-Q · filed 2020-10-30 | $8.24 derived: net income ÷ weighted average shares · filed 2021-02-11 |
| 2019-06-30 | $1.03 10-K · filed 2021-02-11 | $2.06 10-Q · filed 2020-07-31 | $8.03 derived: net income ÷ weighted average shares · filed 2021-02-11 | $8.52 derived: net income ÷ weighted average shares · filed 2021-02-11 |
| 2019-03-31 | $1.03 10-K · filed 2021-02-11 | $7.00 derived: net income ÷ weighted average shares · filed 2021-02-11 | $7.49 derived: net income ÷ weighted average shares · filed 2021-02-11 | $8.30 derived: net income ÷ weighted average shares · filed 2021-02-11 |
| 2018-12-31 | $5.97 10-K · filed 2020-02-13 | $6.46 derived: net income ÷ weighted average shares · filed 2021-02-11 | $7.27 derived: net income ÷ weighted average shares · filed 2021-02-11 | $8.09 10-K · filed 2021-02-11 |
| 2018-09-30 | $0.50 10-K · filed 2020-02-13 | $1.30 derived: net income ÷ weighted average shares · filed 2020-02-13 | $2.11 10-Q · filed 2019-10-31 | $2.50 derived: net income ÷ weighted average shares · filed 2020-02-13 |
| 2018-06-30 | $0.80 10-K · filed 2020-02-13 | $1.61 10-Q · filed 2019-08-01 | $2.01 derived: net income ÷ weighted average shares · filed 2020-02-13 | $1.62 derived: net income ÷ weighted average shares · filed 2020-02-13 |
| 2018-03-31 | $0.81 10-K · filed 2020-02-13 | $1.21 derived: net income ÷ weighted average shares · filed 2020-02-13 | $0.81 derived: net income ÷ weighted average shares · filed 2020-02-13 | $0.89 derived: net income ÷ weighted average shares · filed 2020-02-13 |
| 2017-12-31 | $0.39 10-K · filed 2019-02-13 | -$0.01 derived: net income ÷ weighted average shares · filed 2020-02-13 | $0.06 derived: net income ÷ weighted average shares · filed 2020-02-13 | $1.04 10-K · filed 2020-02-13 |
| 2017-09-30 | -$0.41 10-K · filed 2019-02-13 | -$0.34 derived: net income ÷ weighted average shares · filed 2019-02-13 | $0.64 10-Q · filed 2018-10-25 | $0.78 derived: net income ÷ weighted average shares · filed 2019-02-13 |
| 2017-06-30 | $0.07 10-K · filed 2019-02-13 | $1.06 10-Q · filed 2018-07-26 | $1.20 derived: net income ÷ weighted average shares · filed 2019-02-13 | $1.05 derived: net income ÷ weighted average shares · filed 2019-02-13 |
| 2017-03-31 | $0.99 10-K · filed 2019-02-13 | $1.13 derived: net income ÷ weighted average shares · filed 2019-02-13 | $0.98 derived: net income ÷ weighted average shares · filed 2019-02-13 | $0.72 derived: net income ÷ weighted average shares · filed 2019-02-13 |
| 2016-12-31 | $0.13 10-K · filed 2018-02-15 | -$0.02 derived: net income ÷ weighted average shares · filed 2019-02-13 | -$0.29 derived: net income ÷ weighted average shares · filed 2019-02-13 | -$0.46 10-K · filed 2019-02-13 |
| 2016-09-30 | -$0.16 10-K · filed 2018-02-15 | -$0.42 derived: net income ÷ weighted average shares · filed 2018-02-15 | -$0.59 10-Q · filed 2017-10-30 | |
| 2016-06-30 | -$0.26 10-K · filed 2018-02-15 | -$0.43 10-Q · filed 2017-07-28 | ||
| 2016-03-31 | -$0.17 10-K · filed 2018-02-15 | |||
| 2015-12-31 | -$2.31 10-K · filed 2018-02-15 | |||
| 2015-09-30 | -$0.39 10-Q · filed 2016-10-31 | -$2.00 10-Q · filed 2016-10-31 | ||
| 2015-06-30 | -$0.78 10-Q · filed 2016-08-01 | -$1.61 10-Q · filed 2016-08-01 | ||
| 2015-03-31 | -$0.83 10-Q · filed 2016-05-03 | |||
| 2014-12-31 | -$3.14 10-K · filed 2017-02-23 | |||
| 2014-09-30 | -$0.72 10-Q · filed 2015-10-30 | -$2.40 10-Q · filed 2015-10-30 | ||
| 2014-06-30 | -$0.68 10-Q · filed 2015-08-04 | -$1.68 10-Q · filed 2015-08-04 | ||
| 2014-03-31 | -$1.00 10-Q · filed 2015-05-04 | |||
| 2013-12-31 | $0.19 10-K · filed 2014-02-11 | -$1.98 10-K · filed 2016-02-16 | ||
| 2013-09-30 | -$0.54 10-Q · filed 2014-11-06 | -$2.20 10-Q · filed 2014-11-06 | ||
| 2013-06-30 | -$0.26 10-Q · filed 2014-07-31 | -$1.67 10-Q · filed 2014-07-31 | -$1.39 derived: net income ÷ weighted average shares · filed 2015-02-13 | -$1.66 derived: net income ÷ weighted average shares · filed 2015-02-13 |
| 2013-03-31 | -$1.43 10-Q · filed 2014-05-05 | -$1.14 derived: net income ÷ weighted average shares · filed 2015-02-13 | -$1.41 derived: net income ÷ weighted average shares · filed 2015-02-13 | -$1.72 derived: net income ÷ weighted average shares · filed 2015-02-13 |
| 2012-12-31 | -$0.35 10-K · filed 2014-02-11 | $0.02 derived: net income ÷ weighted average shares · filed 2015-02-13 | -$0.28 derived: net income ÷ weighted average shares · filed 2015-02-13 | -$0.50 10-K · filed 2015-02-13 |
| 2012-09-30 | -$0.27 10-K · filed 2014-02-11 | -$0.58 derived: net income ÷ weighted average shares · filed 2014-02-11 | -$0.15 10-Q · filed 2013-11-07 | $0.60 derived: net income ÷ weighted average shares · filed 2014-02-11 |
| 2012-06-30 | -$0.31 10-K · filed 2014-02-11 | $0.12 10-Q · filed 2013-08-02 | $0.87 derived: net income ÷ weighted average shares · filed 2014-02-11 | $1.89 derived: net income ÷ weighted average shares · filed 2014-02-11 |
| 2012-03-31 | $0.43 10-K · filed 2014-02-11 | $1.16 derived: net income ÷ weighted average shares · filed 2014-02-11 | $2.17 derived: net income ÷ weighted average shares · filed 2014-02-11 | $1.40 derived: net income ÷ weighted average shares · filed 2014-02-11 |
| 2011-12-31 | $0.74 10-K · filed 2013-03-01 | $1.74 derived: net income ÷ weighted average shares · filed 2014-02-11 | $0.97 derived: net income ÷ weighted average shares · filed 2014-02-11 | $0.14 10-K · filed 2014-02-11 |
| 2011-09-30 | $1.02 10-K · filed 2013-03-01 | $0.23 derived: net income ÷ weighted average shares · filed 2013-03-01 | -$0.63 10-Q · filed 2012-11-06 | -$1.49 derived: net income ÷ weighted average shares · filed 2013-03-01 |
| 2011-06-30 | -$0.85 10-K · filed 2013-03-01 | -$1.72 10-Q · filed 2012-08-08 | -$2.62 derived: net income ÷ weighted average shares · filed 2013-03-01 | -$3.66 derived: net income ÷ weighted average shares · filed 2013-03-01 |
| 2011-03-31 | -$0.87 10-K · filed 2013-03-01 | -$1.77 derived: net income ÷ weighted average shares · filed 2013-03-01 | -$2.81 derived: net income ÷ weighted average shares · filed 2013-03-01 | |
| 2010-12-31 | -$0.90 10-K · filed 2012-02-22 | -$1.94 derived: net income ÷ weighted average shares · filed 2013-03-01 | -$3.77 10-K · filed 2013-03-01 | |
| 2010-09-30 | -$1.04 10-K · filed 2012-02-22 | -$2.87 10-Q · filed 2011-11-03 | ||
| 2010-06-30 | -$1.00 10-K · filed 2012-02-22 | -$1.83 10-Q · filed 2011-08-09 | ||
| 2010-03-31 | -$0.83 10-K · filed 2012-02-22 | |||
| 2009-12-31 | -$0.86 10-K · filed 2011-02-17 | -$3.71 10-K · filed 2012-02-22 | ||
| 2009-09-30 | -$0.84 10-K · filed 2011-02-17 | -$2.86 10-Q · filed 2010-10-28 | ||
| 2009-06-30 | -$0.99 10-K · filed 2011-02-17 | -$2.03 10-Q · filed 2010-08-03 | ||
| 2009-03-31 | -$1.04 10-K · filed 2011-02-17 | |||
| 2008-12-31 | -$3.27 10-K · filed 2011-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |